Gregg L Semenza
Präsident bei The Johns Hopkins University School of Medicine
Profil
Gregg L Semenza is the Director at the Institute For Cell Engineering.
He is also a Professor of Genetic Medicine at The Johns Hopkins University School of Medicine since 1990.
Additionally, he is a Venture Partner at Catalio Capital Management LP and an Advisor at Medical Excellence Capital LLC.
Semenza holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Harvard College.
Aktive Positionen von Gregg L Semenza
Unternehmen | Position | Beginn |
---|---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | Berater | - |
The Johns Hopkins University School of Medicine | Präsident | 01.01.1990 |
Institute For Cell Engineering | Direktor/Vorstandsmitglied | - |
Ausbildung von Gregg L Semenza
Harvard College | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
Medical Excellence Capital LLC
Medical Excellence Capital LLC Investment ManagersFinance Medical Excellence Capital LLC (MEC) is a venture capital firm founded in 2020 by John R. Prufeta. The firm is headquartered in New York City. | Finance |
Institute For Cell Engineering |